- Report
- July 2023
- 81 Pages
Global
From €3500EUR$4,294USD£3,136GBP
- Report
- November 2025
- 132 Pages
Global
From €829EUR$950USD£718GBP
- Report
- November 2025
- 132 Pages
Global
From €829EUR$950USD£718GBP
- Report
- January 2025
- 132 Pages
Global
From €829EUR$950USD£718GBP
- Report
- January 2025
- 132 Pages
Global
From €829EUR$950USD£718GBP
- Report
- January 2025
- 132 Pages
Global
From €829EUR$950USD£718GBP
- Report
- November 2021
- 1112 Pages
Global
From €5239EUR$6,000USD£4,535GBP
- Report
- November 2021
- 545 Pages
Global
From €3493EUR$4,000USD£3,024GBP
- Report
- November 2021
- 233 Pages
Global
From €2183EUR$2,500USD£1,890GBP
The Digital Polymerase Chain Reaction (dPCR) market is a subset of the genomics industry. It is a technology used to detect and quantify nucleic acid molecules, such as DNA and RNA. It is a highly sensitive and specific method for detecting and quantifying nucleic acid molecules, and is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics. dPCR is also used in research and development, as well as in clinical settings.
dPCR is a cost-effective and efficient method for detecting and quantifying nucleic acid molecules, and is becoming increasingly popular in the genomics industry. It is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics.
Some companies in the dPCR market include Bio-Rad, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Illumina. Show Less Read more